This topic contains a solution. Click here to go to the answer

Author Question: Control goals of operations processes include: a. validity b. the control environment c. accuracy ... (Read 106 times)

mspears3

  • Hero Member
  • *****
  • Posts: 586
Control goals of operations processes include:
 a. validity
  b. the control environment
  c. accuracy
  d. security of resources

Question 2

Reader, Inc collected 12,000 in October 2011 from customers in exchange for 12-month subscriptions to its monthly magazine Reader. The October issue was the first issue of the subscription.
 
  How much revenue should the company report on its income statement for the year ended March 31, 2012?
  A) 12,000
  B) 8,000
  C) 6,000
  D) No revenue will be recognized until all the magazines are delivered.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

D

Answer to Question 2

C




mspears3

  • Member
  • Posts: 586
Reply 2 on: Jul 5, 2018
Wow, this really help


sailorcrescent

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library